CLINICAL ROLE -
Pharmacist-Administered ART Adherence Clinic Makes Inroads
Pharmacists can resolve ART adherence problems to achieve HIV viral suppression
Read More
FDA Seeks to Improve Global Pharmaceutical Manufacturing Inspections
Some therapies approved in the United States are either fully manufactured overseas or made domestically but contain some foreign ingredients.
What Pharmacists Need to Know About President Trump's Health Care Executive Order
Secretary of Labor to consider expanding access to Association Health Plans, which could allow employers to form groups across state lines.
FDA Seeks Higher Production Standards for Compounded Drugs
The Drug Quality and Security Act provides a foundation for improving the safety of drug compounding by working with outsourcing facilities to meet regulatory standards.
Ending DIR Fees Could Save Medicare Billions Tops SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
FDA Requests Additional Data on Sirukumab for Rheumatoid Arthritis
Sirukumab is an anti-interleukin-6 monoclonal antibody designed to block the IL-6 pathway in a different way than currently approved IL-6 inhibitors.
Cost of Hepatitis C Antivirals May Keep Patients Away Tops SPT Week in Review
United States Ramps Up HIV Prevention Efforts
New PEPFAR strategy supports HIV/AIDS prevention efforts in more than 50 countries.
FDA Approves First Biosimilar for Cancer Treatment Highlights SPT Week in Review
Top 10 Dirtiest Places in Pharmacy Highlights SPT Week in Review
Biosimilar, Gene Therapy Approval Top SPT Week in Review
Top articles of the week from Specialty Pharmacy Times.
List of New Specialty Drug Indications Highlight SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
NASP Launches Website to Combat Harmful DIR Fees Tops SPT Week in Review
Controversial DIR Fees Highlight SPT Week in Review
FDA Drug Approvals Highlights SPT Week in Review
World Hepatitis Day Tops SPT Week in Review
USPSTF Advises Against Routine Ovarian Cancer Screening
US Preventive Services Task Force states that screening tests for ovarian cancer are often inaccurate.
FDA Delays Decision on Rheumatoid Arthritis Drug
The FDA is requesting a new clinical study before evaluating a new drug application for baricitinib, an oral medication for moderate-to-severe rheumatoid arthritis.
Tapping Specialty Market Potential Tops SPT Week in Review
Biosimilar Launch Considerations Highlight SPT Week in Review
Atopic Dermatitis Drug Trial Underway Highlights SPT Week in ReviewÂ
Future of Specialty Pharmacy Highlights SPT Week in Review
Cancer Drug Approvals Highlight SPT Week in Review
Top articles of the week on Specialty Pharmacy Times.
Lifelong Learning in Specialty Pharmacy Highlights SPT Week in Review
RA Treatment Advances Highlight SPT Week in Review
Liver, Gastric Cancer Priority Reviews Highlight Week in Cancer News
Top news of the week in oncology and cancer drug development.
Students in Specialty Highlights SPT Week in Review
What Comprises an Effective Patient Care Program?
Cheryl Allen, vice president of Industry Relations at Diplomat Specialty Pharmacy, discusses the elements of an effective, high touch patient care program.
Pharmacy Patient Satisfaction Highlights SPT Week in Review
T Cell Therapy Trial Death in Top Cancer News of the Week
